Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Applied DNA Sciences, Inc. - Common Stock (NQ: APDN )

2.260 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 94,384
Open 2.260
Bid (Size) 2.220 (1)
Ask (Size) 2.270 (1)
Prev. Close 2.260
Today's Range 2.260 - 2.260
52wk Range 0.0507 - 10.44
Shares Outstanding 54,111,523
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's after hours session
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
Top movers analysis one hour before the close of the markets on 2025-03-14: top gainers and losers in today's session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill

Performance

YTD
+814.98%
+814.98%
1 Month
+1228.63%
+1228.63%
3 Month
+1122.94%
+1122.94%
6 Month
+69.92%
+69.92%
1 Year
-74.32%
-74.32%

More News

Read More
Which stocks are experiencing notable movement on Friday?
Via Chartmill
Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress
Via ACCESS Newswire
Earnings Scheduled For February 13, 2025
Via Benzinga
Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025
Via ACCESS Newswire
Which stocks are gapping on Friday?
Via Chartmill
What's going on in today's pre-market session
Via Chartmill
Top movers in Wednesday's session
Via Chartmill
Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates
Via ACCESSWIRE
Which stocks are experiencing notable movement on Wednesday?
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
Get insights into the top gainers and losers of Wednesday's pre-market session.
Via Chartmill
Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025
Via ACCESS Newswire
Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14
Via ACCESS Newswire
Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
Via ACCESSWIRE
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA
Via ACCESSWIRE
US Stocks To Open Higher As Rate Cut Expectations Surge: All Eyes On Dow Jones To Break Its 9-Day Losing Streak
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Via Benzinga
General Mills, Micron Technology And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
Via ACCESSWIRE
Earnings Scheduled For December 17, 2024
Via Benzinga
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out
Via ACCESSWIRE
Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecast
Via Benzinga
Exposures Fossil Fuels
S&P 500 Edges Lower; US Crude Oil Inventories Fall
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.